Virtual Dignity Therapy for Palliative Care Patients with Advanced Cancer

Overview

About this study

The purpose of this study is to determine if it is feasible to recruit for and deliver the Virtual Dignity Therapy intervention to palliative care patients with advanced cancer and whether the intervention is beneficial in terms of improvement in distress, patient dignity, and quality of life.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years.
  • English fluency.
  • No diagnosed dementia.  
  • Diagnosis of advanced cancer.  
  • Expected prognosis > 6 months.
  • Provide informed consent.
  • Ability to complete questionnaire(s) by themselves or with assistance.

Exclusion Criteria:

  • Other psychological co-morbidities such as untreated schizophrenia, bipolar disease.
  • Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months.
  • Active delirium.
  • Participation in concurrent legacy offerings through the palliative care clinic.

Eligibility last updated 10/26/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Deirdre Pachman, M.D.

Closed for enrollment

Contact information:

Department of Medicine - Clinical Trials Unit

(507) 266-1944

RSTDOMCTU@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions